These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
319 related items for PubMed ID: 15524097
1. [On the relevance of protein kinase C to lithium therapy in bipolar disorder]. Sela B. Harefuah; 2004 Jun; 143(6):414-6, 462. PubMed ID: 15524097 [Abstract] [Full Text] [Related]
2. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications. Manji HK, Bebchuk JM, Moore GJ, Glitz D, Hasanat KA, Chen G. J Clin Psychiatry; 1999 Jun; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385 [Abstract] [Full Text] [Related]
3. Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain? Lenox RH, McNamara RK, Watterson JM, Watson DG. J Clin Psychiatry; 1996 Jun; 57 Suppl 13():23-31; discussion 32-3. PubMed ID: 8970502 [Abstract] [Full Text] [Related]
4. Sodium valproate down-regulates the myristoylated alanine-rich C kinase substrate (MARCKS) in immortalized hippocampal cells: a property of protein kinase C-mediated mood stabilizers. Watson DG, Watterson JM, Lenox RH. J Pharmacol Exp Ther; 1998 Apr; 285(1):307-16. PubMed ID: 9536026 [Abstract] [Full Text] [Related]
5. [Possible involvement of protein kinase C in the pathophysiology and treatment of bipolar disorder]. Einat H, Chen G, Manji H. Harefuah; 2004 Jun; 143(6):420-5, 462. PubMed ID: 15524099 [Abstract] [Full Text] [Related]
6. Neurobiology of lithium: an update. Lenox RH, McNamara RK, Papke RL, Manji HK. J Clin Psychiatry; 1998 Jun; 59 Suppl 6():37-47. PubMed ID: 9674936 [Abstract] [Full Text] [Related]
7. Regulation of signal transduction pathways by mood-stabilizing agents: implications for the delayed onset of therapeutic efficacy. Manji HK, Chen G, Hsiao JK, Risby ED, Masana MI, Potter WZ. J Clin Psychiatry; 1996 Jun; 57 Suppl 13():34-46; discussion 47-8. PubMed ID: 8970503 [Abstract] [Full Text] [Related]
8. Overview of the mechanism of action of lithium in the brain: fifty-year update. Lenox RH, Hahn CG. J Clin Psychiatry; 2000 Jun; 61 Suppl 9():5-15. PubMed ID: 10826655 [Abstract] [Full Text] [Related]
10. Long-term action of lithium: a role for transcriptional and posttranscriptional factors regulated by protein kinase C. Manji HK, Lenox RH. Synapse; 1994 Jan; 16(1):11-28. PubMed ID: 8134897 [Abstract] [Full Text] [Related]
11. [Predictors of prophylactic response to lithium]. Rohayem J, Baylé JF, Richa S. Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242 [Abstract] [Full Text] [Related]
18. Pharmacogenetics of lithium response in bipolar disorder. Alda M. J Psychiatry Neurosci; 1999 Mar; 24(2):154-8. PubMed ID: 10212559 [Abstract] [Full Text] [Related]
19. Cellular mechanisms and second messengers: relevance to the psychopharmacology of bipolar disorders. Brunello N, Tascedda F. Int J Neuropsychopharmacol; 2003 Jun; 6(2):181-9. PubMed ID: 12890311 [Abstract] [Full Text] [Related]
20. Anticonvulsants in bipolar disorder. Singh V, Muzina DJ, Calabrese JR. Psychiatr Clin North Am; 2005 Jun; 28(2):301-23. PubMed ID: 15826734 [Abstract] [Full Text] [Related] Page: [Next] [New Search]